Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Bsteh

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
Frontiers in Neurology|March 24, 2022
Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple SclerosisNik Krajnc, Patrick Altmann, Katharina Riedl, et al.
Headache|February 8, 2023
Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomesGabriel Bsteh, Stefan Macher, Nik Krajnc, et al.
European Journal of Radiology|December 18, 2021
Imaging features to distinguish AQP4-positive NMOSD and MS at disease onset: A retrospective analysis in a single-center cohortTobias Zrzavy, Fritz Leutmezer, Paulus Rommer, et al.
Wiener Klinische Wochenschrift|August 31, 2023
The Vienna idiopathic intracranial hypertension database-An Austrian registryPhilip Pruckner, Christoph Mitsch, Stefan Macher, et al.
Wiener Medizinische Wochenschrift (1946)|February 10, 2022
Natalizumab treatment during pregnancy in multiple sclerosis-clinical and bioethical aspects of an ongoing debateKlaus Berek, Claudia Paganini, Harald Hegen, et al.
Scientific Reports|December 15, 2023
Subarachnoid haemorrhage or traumatic lumbar puncture. Differentiation by cerebrospinal fluid parameters in a multivariable approachAnne Zinganell, Klaus Berek, Gabriel Bsteh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 23, 2018
Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegenerationGabriel Bsteh, Klaus Berek, Harald Hegen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 22, 2016
Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factorsGabriel Bsteh, Julia Feige, Rainer Ehling, et al.
Frontiers in Immunology|November 10, 2018
Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple SclerosisHarald Hegen, Janette Walde, Gabriel Bsteh, et al.
Multiple Sclerosis and Related Disorders|April 27, 2025
Clinical characteristics and outcome of double-AQP4/MOG-seronegative and not MS-associated monophasic and relapsing demyelinating transverse myelitis: A monocenter studyMichael Auer, Harald Hegen, Franziska Di Pauli, et al.
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
Frontiers in Neurology|March 24, 2022
Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple SclerosisNik Krajnc, Patrick Altmann, Katharina Riedl, et al.
Headache|February 8, 2023
Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomesGabriel Bsteh, Stefan Macher, Nik Krajnc, et al.
European Journal of Radiology|December 18, 2021
Imaging features to distinguish AQP4-positive NMOSD and MS at disease onset: A retrospective analysis in a single-center cohortTobias Zrzavy, Fritz Leutmezer, Paulus Rommer, et al.
Wiener Klinische Wochenschrift|August 31, 2023
The Vienna idiopathic intracranial hypertension database-An Austrian registryPhilip Pruckner, Christoph Mitsch, Stefan Macher, et al.
Wiener Medizinische Wochenschrift (1946)|February 10, 2022
Natalizumab treatment during pregnancy in multiple sclerosis-clinical and bioethical aspects of an ongoing debateKlaus Berek, Claudia Paganini, Harald Hegen, et al.
Scientific Reports|December 15, 2023
Subarachnoid haemorrhage or traumatic lumbar puncture. Differentiation by cerebrospinal fluid parameters in a multivariable approachAnne Zinganell, Klaus Berek, Gabriel Bsteh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 23, 2018
Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegenerationGabriel Bsteh, Klaus Berek, Harald Hegen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 22, 2016
Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factorsGabriel Bsteh, Julia Feige, Rainer Ehling, et al.
Frontiers in Immunology|November 10, 2018
Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple SclerosisHarald Hegen, Janette Walde, Gabriel Bsteh, et al.
Multiple Sclerosis and Related Disorders|April 27, 2025
Clinical characteristics and outcome of double-AQP4/MOG-seronegative and not MS-associated monophasic and relapsing demyelinating transverse myelitis: A monocenter studyMichael Auer, Harald Hegen, Franziska Di Pauli, et al.
Pageof 17